Actemra and Basaglar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actemra (tocilizumab) and Basaglar (insulin glargine). Common drug interactions include oxygen saturation decreased among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Actemra and Basaglar. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 102,759 Actemra users. Check the latest studies of Actemra.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

On Jul, 07, 2026

18 people who take Actemra and Basaglar together, and have interactions are studied.

What are the common drug interactions of Actemra and Basaglar, by gender? *:

female:

Oxygen saturation decreased
Blindness
Blood pressure systolic increased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea
Haematochezia (passage of stools containing blood)
Infusion related reaction
Lower respiratory tract infection
Peptic ulcer
Pneumonia

male:

Arthralgia (joint pain)
Blood glucose increased
Burning sensation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Headache (pain in head)
Joint stiffness
Muscular weakness (muscle weakness)
Pain in jaw
Thrombosis (formation of a blood clot inside a blood vessel)
Vision blurred

What are the common drug interactions of Actemra and Basaglar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Neutropenia (an abnormally low number of neutrophils)

50-59:

Asthma

60+:

Oxygen saturation decreased
Blood pressure systolic increased
Application site discomfort
Application site erythema (redness of the skin at application site)
Application site pruritus (application site severe itching of the skin)
Balance disorder
Burning sensation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dizziness
Dysuria (painful or difficult urination)

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 16.67%
Cyclitis (inflammation of the ciliary body (eye)): 3 people, 16.67%
Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 3 people, 16.67%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 3 people, 16.67%
Type 2 Diabetes: 2 people, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 1 person, 5.56%
Cardiac Failure Congestive: 1 person, 5.56%
Diabetes: 1 person, 5.56%
Fungal Infection: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Actemra and Basaglar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously